Pharmaceutical Industry
Why the drug industry and its friends are holding their fire on RFK Jr.
RFK Plans to Take on Big Pharma. It’s Easier Said Than Done
Indian pharma sector 3rd largest globally, valued at $50 billion in FY 2023-24: Centre
Warren, Smith reintroduce bill to strengthen US pharmaceutical supply chains
Reactwise Launches Cutting-Edge AI-Driven Technology to Transform the Global Pharmaceutical Landscape
Major pharmaceutical companies set sights on AI startups
The pharma industry’s silence on RFK Jr., and efforts by parents to develop gene therapies for their children
AbbVie, Novartis and drug industry win court battle in larger 340B war
Drugs Licensed
New program to license Pa. telehealth drug and alcohol treatment providers
In weight loss battle, Novo and Lilly face growing offensive from licensed copies
FDA declares shortage over for popular weight-loss, diabetes drugs
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
Pyxis Oncology shelves antibody to focus on sole clinical asset, an ADC licensed from Pfizer
US FDA warns online vendors selling unapproved weight-loss drugs
Drugs Patents
The Connection Between Patents and High Drug Prices
Teva loses US appeal to keep inhaler patents on FDA protected drug list
Drug Delivery Device Patents Removed from Orange Book
Sarepta wins $115.2 million US drug patent verdict from Japan's Nippon Shinyaku
Amgen hit with $50.3 mln US verdict in cancer drug patent lawsuit
House Republicans abandon PBM reform in push to keep government open
Opinion: Lessons From Humira on How to Tackle Unjust Extensions of Drug Monopolies With Policy
Teva Must Delist Asthma-Inhaler Patents, Appeals Court Rules (1)
Drugs Generics
Making affordable generics more reliable
Sandoz Boss Warns There’s a Climate Cost of Obesity Wonder Drugs
Penn Medicine partners with Mark Cuban’s pharmacy company to source generic medications for retail locations
Sandoz takes further steps to resolve legacy U.S. Generic Drug Antitrust Class Action litigation
What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices for everyone
Litigation Surge: Drugmakers Launch Flood of Suits to Halt Generics
Penn Medicine will buy drugs from Mark Cuban’s Cost Plus Marketplace in bid to boost profit margin
Alembic Gets USFDA Nod for Generic Anti-Epileptic Drug
Saudi Arabia Generic Drugs Market Report 2024, By Region, Competition, Forecast and Opportunities to 2029
FDA Food and Drug Administration
FDA issues recall on popular dog treat sold in 19 states that can kill pets
FDA clears Ionis drug as first therapy for rare disease FCS
Pharmaceutical Companies
Major pharmaceutical companies set sights on AI startups
Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025?
Orlando pharmaceutical company to launch new brand, add 100 jobs here
Is Recursion Pharmaceuticals Stock a Millionaire Maker?
Pharmaceutical Mole aka VA Under Secretary Pushes Ecstasy on Our Nation’s Vets
Stocks to Watch: Rumble, Lexicon Pharmaceuticals
How Pharma Companies Can Balance Affordability With Innovation
Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting
Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals